In January 2017, AMCP co-sponsored a conference with the PhRMA Foundation on the use of CER and PCOR by patients, clinicians, and payers. The conference centered on existing strategies to enhance uptake and use of CER/PCOR, as well as the needs and gaps in the uptake and use of CER/PCOR evidence.
This glossary defines or describes terminology used in comparative clinical effectiveness research for managed care pharmacy professionals. For cost effectiveness terminology, please see other resources, such as Health Care Cost, Quality, and Outcomes: ISPOR Book of Terms. Lawrenceville, NJ: International Society for Pharmacoeconomics and Outcomes Research; 2003.
This glossary defines or describes terminology used in comparative clinical effectiveness research for managed care pharmacy professionals. For cost effectiveness terminology, please see other resources, such as Health Care Cost, Quality, and Outcomes: ISPOR Book of Terms. Lawrenceville, NJ: International Society for Pharmacoeconomics and Outcomes Research; 2003.
The purpose of this glossary is to define or describe terminology used in comparative clinical effectiveness research for managed care pharmacy professionals.